Research, development, production and distribution of nutritional health supplements,
dermocosmetics, dietary foods for special medical purposes and medical devices
<a href="/events">We will be present </a>
<a href="/about-us/quality">Certified quality</a>

Amnol is committed to maintaining the quality of its products and manufacturing processes, proven by n.6860A ISO 9001:2008 certification. The company guarantees excellence in its nutritional health supplements, dermocosmetics and medical devices by means of scrupulous methods of control and state of the art instruments, thus safeguarding the well-being of end-users.

<a href="/expert">Ask the expert</a>

Our experts are at your disposal for any enquiries you may have regarding Amnol's products and will respond to your requests for any further information or informative literature. Please contact them by email or call on our toll free number.

News from the world

News from the world

  • Summaries of recent phlebological abstracts.
    Authors: Kabnick L, Almeida J PMID: 27530429 [PubMed - in process] (Source: Phlebology)
  • Comparison of microbubble presence in the right he...
    CONCLUSION: A comparable prevalence of microbubbles between mechanochemical abaltion and radiofrequency ablation both of which are...
  • Parkes Weber syndrome-Diagnostic and management pa...
    CONCLUSION: A diagnosis of Parkes Weber syndrome should be made on the presence of capillary malformation, venous malformation, ly...
  • Summaries of recent phlebological abstracts.
    Authors: Kabnick L, Almeida J PMID: 27440723 [PubMed - in process] (Source: Phlebology)
  • Letter regarding the role of radical surgery in th...
    Authors: Whiteley MS PMID: 27440460 [PubMed - as supplied by publisher] (Source: Phlebology)
  • A randomized prospective long-term ( > 1 year) cli...
    CONCLUSIONS: Radiofrequency ablation and endovenous laser ablation are highly effective and safe from both anatomic and clinical s...
  • Thoracic magnetic resonance venography using Gadof...
    CONCLUSION: Our results show that Gadofosveset-enhanced magnetic resonance venography of the central thoracic veins is a reliable ...
  • Corrigendum to arteriovenous fistula geometry in h...
    Authors: PMID: 27383474 [PubMed - as supplied by publisher] (Source: Phlebology)
  • Response to letter regarding Embolization is not e...
    Authors: Rabe E, Pannier F PMID: 27380947 [PubMed - as supplied by publisher] (Source: Phlebology)
  • Summaries of recent phlebological abstracts.
    Authors: Kabnick L, Almeida J PMID: 27259976 [PubMed - in process] (Source: Phlebology)
Newsletter

Newsletter

Sign up to our newsletter to keep up-to-date about what's new at AMNOL.








AMNOL Chimica Biologica S.r.l.
Registered office, Administrative and Sales Offices: Corso della Vittoria 14, 28100 Novara
Tel: +39 0321 499199 - Email: info@amnol.net
Share Capital € 250,000 issued capital R.E.A. Novara 10937 VAT code 01228730030 Tax Code 04170400156



AMNOL Chimica Biologica and Euronational are companies of the WTB group (company subject to management and co-ordination activity pursuant to Art.2497 CC by WTB Holding S.p.A. - Milan)


Quality Management System Certified by KIWA CERMET according to the UNI EN ISO 9001:2008 Reg No. 6860-A.

Copyright 2016 by Amnol Chimica Biologica